Product Description
Overall, the global phakic intraocular lens market was valued at approximately $209 million in 2022. This is expected to increase over the forecast period at a CAGR of 5.9% to reach approximately $312 million.
Throughout this medical market research, we analyzed over 5 phakic intraocular lens companies across 7 continents and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts. The full report suite on the global ophthalmic ultrasound device market includes a complete analysis on phakic intraoculaer lenses.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2029, and Historical Data to 2019
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- COVID19 Impact
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
Global Phakic Intraocular Lens Market Insights
Refractive surgeries are usually chosen as elective procedures, and their demand can be influenced by economic fluctuations due to the costs involved for patients. Phakic implantation and LASIK are two competitive options in the field of refractive surgeries. However, LASIK tends to be the more preferred choice for most individuals, primarily because it is a more cost-effective option compared to phakic IOL implantation. This preference is evident in the fact that only a minority of refractive surgeries involve the use of phakic IOLs.
Global Phakic Intraocular Lens Market Share Insights
In 2022, STAAR Surgical Company secured the top position as the dominant player in the worldwide phakic IOL market, with their flagship product being the Visian ICL™.
AMO, during the same year, emerged as the second major contender in the global phakic IOL market, boasting the Verisyse® phakic IOL as their primary offering.
Alcon held the third-place position among competitors in the global phakic IOL market for 2022, primarily known for its AcrySof® cataract IOLs, celebrated for their effectiveness in cataract surgery lens replacements.
Market Segmentation Summary
- Global Phakic Intraocular Lens Market
Global Phakic Intraocular Lens Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2022 |
| Forecast | 2023-2039 |
| Historical Data | 2019-2022 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
